Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Bass, Berry & Sims Bolsters Intellectual Property Practice with Addition of Michael L. Kiklis in Washington, D.C. Office

August 6, 2018

Washington, D.C., August 6, 2018 – Bass, Berry & Sims PLC is pleased to announce the addition of Michael L. Kiklis as a member in the firm's Washington, D.C. office. Kiklis joins the firm's Intellectual Property & Technology practice, bringing 25 years of experience representing clients in patent matters, including litigation and trials at the U.S. Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB). Kiklis has been involved in approximately 100 PTAB trials, serving as lead counsel in a vast majority of those cases, and also handles appeals to the Federal Circuit. He has an extensive background in computer science based on his prior work as a software developer at some of the computer industry's leading companies.

"Mike brings a deep knowledge of the business and legal challenges our clients may face, especially in the technology space, informed by years of hands-on experience counseling clients through nearly every type of patent matter," said Todd Rolapp, managing partner at Bass, Berry & Sims. "Mike's extensive experience in PTAB litigation adds depth to our comprehensive IP practice."

Kiklis represents clients in a wide range of patent matters, ranging from bet-the-company PTAB trials and patent litigation to cross-licensing and due diligence. He frequently serves as lead counsel in inter partes review and covered business method patent review proceedings and coordinates concurrent or multiple proceedings related to the same patent. He also assists clients in enforcing and defending their intellectual property rights related to patent infringement in alternative dispute resolution forums, district courts, and the Federal Circuit. 

Kiklis is a frequent speaker and author providing influential thought leadership on patent law, including patentable subject matter and PTAB trials. He is the author of The Supreme Court on Patent Law, which is an 800-page treatise devoted to the Supreme Court's patent law jurisprudence.

Kiklis earned his undergraduate degree at the University of Massachusetts – Lowell, his master's degree from Boston University and his law degree from the Syracuse University College of Law.

About Bass, Berry & Sims PLC
With more than 270 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims PLC has been involved in some of the largest and most significant business transactions, investigations and litigation matters in the country. For more information, visit

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.